BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21193740)

  • 1. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.
    Boström KI; Jumabay M; Matveyenko A; Nicholas SB; Yao Y
    Circ Res; 2011 Feb; 108(4):446-57. PubMed ID: 21193740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.
    Yao Y; Zebboudj AF; Shao E; Perez M; Boström K
    J Biol Chem; 2006 Nov; 281(45):33921-30. PubMed ID: 16950789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2.
    Yao Y; Shao ES; Jumabay M; Shahbazian A; Ji S; Boström KI
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2266-74. PubMed ID: 18948634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the endothelium in vascular calcification.
    Yao Y; Jumabay M; Ly A; Radparvar M; Cubberly MR; Boström KI
    Circ Res; 2013 Aug; 113(5):495-504. PubMed ID: 23852538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein.
    Yao Y; Watson AD; Ji S; Boström KI
    Circ Res; 2009 Sep; 105(6):575-84. PubMed ID: 19661459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4.
    Yao Y; Shahbazian A; Boström KI
    Circ Res; 2008 May; 102(9):1065-74. PubMed ID: 18369157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency.
    Malhotra R; Burke MF; Martyn T; Shakartzi HR; Thayer TE; O'Rourke C; Li P; Derwall M; Spagnolli E; Kolodziej SA; Hoeft K; Mayeur C; Jiramongkolchai P; Kumar R; Buys ES; Yu PB; Bloch KD; Bloch DB
    PLoS One; 2015; 10(1):e0117098. PubMed ID: 25603410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells.
    Boström K; Zebboudj AF; Yao Y; Lin TS; Torres A
    J Biol Chem; 2004 Dec; 279(51):52904-13. PubMed ID: 15456771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cells modulate osteogenesis in calcifying vascular cells.
    Shin V; Zebboudj AF; Boström K
    J Vasc Res; 2004; 41(2):193-201. PubMed ID: 15031603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium.
    Yao Y; Jumabay M; Ly A; Radparvar M; Wang AH; Abdmaulen R; Boström KI
    Blood; 2012 May; 119(21):5037-47. PubMed ID: 22474252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification.
    Yao Y; Bennett BJ; Wang X; Rosenfeld ME; Giachelli C; Lusis AJ; Boström KI
    Circ Res; 2010 Aug; 107(4):485-94. PubMed ID: 20576934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.
    Lomashvili KA; Wang X; Wallin R; O'Neill WC
    J Biol Chem; 2011 Aug; 286(33):28715-28722. PubMed ID: 21705322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Gla protein deficiency causes arteriovenous malformations in mice.
    Yao Y; Jumabay M; Wang A; Boström KI
    J Clin Invest; 2011 Aug; 121(8):2993-3004. PubMed ID: 21765215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenic protein-4-induced oxidant signaling via protein carbonylation for endothelial dysfunction.
    Wong CM; Zhang Y; Huang Y
    Free Radic Biol Med; 2014 Oct; 75():178-90. PubMed ID: 25091895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
    Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
    Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
    Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
    J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development.
    Yao Y; Nowak S; Yochelis A; Garfinkel A; Boström KI
    J Biol Chem; 2007 Oct; 282(41):30131-42. PubMed ID: 17670744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.
    Zhang Y; Liu J; Tian XY; Wong WT; Chen Y; Wang L; Luo J; Cheang WS; Lau CW; Kwan KM; Wang N; Yao X; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):152-9. PubMed ID: 24202302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Morphogenic Protein 4 Mediates NOX1-Dependent eNOS Uncoupling, Endothelial Dysfunction, and COX2 Induction in Type 2 Diabetes Mellitus.
    Youn JY; Zhou J; Cai H
    Mol Endocrinol; 2015 Aug; 29(8):1123-33. PubMed ID: 26121233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.